https://fragilexnewstoday.com/news/afuresertib-block-akt-enzyme-exciting-fragile-x-news/
0
0
36 words
0
Comments
Researchers are using the investigational cancer medicine afuresertib to block the AKT enzyme in nerual stem cells that lack the FMRP protein.
You are the first to view
Create an account or login to join the discussion